Annual Drug Patent Expirations for VALTOCO
Valtoco is a drug marketed by Neurelis Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
Drug patent litigation for VALTOCO.
This drug has eigthy-four patent family members in twenty-eight countries.
The generic ingredient in VALTOCO is diazepam. One supplier is listed for this compound. Additional details are available on the diazepam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
